The Research database — Pharma Nord's Foundation
Pharma Nord's research department is always at the forefront of the latest international nutrition science. Scientific studies and articles are carefully registered and catalogued in the most comprehensive research database of the industry, currently holding more than 9,000 scientific references. A considerably amount of these studies has been conducted using Pharma Nord's own products. The research database is continuously revised whenever new studies of relevance to Pharma Nord's products are published. The research department's library is a vital tool for developing new products and improving existing ones.
300 Published Studies with Pharma Nord Products
Besides the many scientific articles and studies used by Pharma Nord as a foundation for developing new products and improving or updating those that already exist, the company has conducted over 300 published studies with products of its own. This research is the cornerstone of the entire documentation that is so vital for the success of Pharma Nord's products. New titles are continuously added to database.
Over the years, Pharma Nord has established a comprehensive international network of scientists in areas such as cardiology, oncology, odontology, surgery, dietary technology and several others. This collaboration, and the ongoing dialogue with researchers, is an extremely important tool for the development of our products.
Pharma Nord and Heart Research
Pharma Nord actively supports science in its quest for new treatments, particularly with the aim of increasing quality of life for people who, due to age or illness, can benefit from Myoqinon, which is a drug for preventing and treating coenzyme Q10 deficiency. Among other things, Pharma Nord's preparations were used in the Swedish KiSel-10 study, where Q10 and selenium supplements were given to healthy seniors. Q-Symbio, a large, multinational study was also conducted with Q10 from Pharma Nord. Both studies were completed with exceptional results.
Pharma Nord and Cancer Research
The battle against cancer is one of medical science's greatest challenges. Pharma Nord is actively involved in international research in cancer prevention and treatment. One of the largest and most ambitious planned European research projects in this area to date is the international PRECISE study. Pharma Nord supplied both the selenium tablets and placebo tablets for the PRECISE pilot study. The PRECISE study that is planisned to include 35-40,000 volunteers from Denmark, Sweden, and England, has not yet receieved funding.
Pharma Nord has also supplied preparations for a large multicenter study of bladder cancer with patients from centers in Belgium, France, and England.
Because of its good and well-documented bioavailability, Pharma Nord's coenzyme Q10 preparation, Myoqinon, is a reference product for the International Coenzyme Q10 Association and has been tested in more than 70 studies. This research is one of the main reasons why the preparation has documentation for its good bio-availability. What is more, Myoquinon has been on the market for over 20 years, which vouches for its good safety data.
Conferences & Symposiums
In some areas, new scientific findings are spawned at such rapid intervals that it is feasible to arrange regular symposiums, where scientists from all over the world gather to present some of the latest scientific breakthroughs. In many cases, Pharma Nord hosts or co-hosts these events. So far, scientific symposiums and conferences have been arranged in research areas such as Q10, CLA, and selenium.
The consumers' own experience is of invaluable importance to both our existing products and those to come. Although consumer experience can hardly be classified as "scientific documentation" it still gives a clue as to whether or no the preparations have an effect and are generally safe for short- or long-term consumption. For this reason, Pharma Nord regards every type of consumer feedback as something of enormous value, and we actively encourage consumers to contact us if they have a story that is worth telling.